Why new obesity medications for teens could be a game changer
When I first saw the CDC’s MMWR latest report on obesity medication prescribing for adolescents, my initial reaction was probably the same as yours: less than 1 percent of teens with obesity got these medications in 2023? That seems pretty dismal.
But then I took a step back and looked at what this data is telling us. And honestly? We’re missing the real story here.
We’re witnessing something historic.
Think about where …








![Catching type 1 diabetes before it becomes life-threatening [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-2-190x100.jpg)


![Tangible support saves health care workers from systemic collapse [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-4-190x100.jpg)
